National Medical Care (Care)
4005 · TASI — Main Market · 2026-07-29
Download report (PDF)
Snapshot Price 108.00 SAR
Market cap 4.84B SAR
P/E 15.21×
P/B 2.62×
ROE 17.22%
Dividend yield 1.85%
Revenue CAGR 20.36%
Valuation (Hajras) Fair value 71.32 SAR
Rating overvalued
Upside/(downside) -33.97%
DCF 60.19
DDM 29.41
Graham 80.36
Discount rate 9.98%
DCF growth 8.00%
Financials SAR FY22 FY23 FY24 FY25 Revenue 917.93M 1.08B 1.29B 1.60B Net income 170.07M 240.93M 294.70M 318.47M EPS 3.79 5.37 6.57 7.10 DPS 1.00 1.00 2.00 1.99 Equity 1.26B 1.45B 1.63B 1.85B
Analyst Price Targets Consensus (median) — SAR
Range — – — SAR
Aljazira Capital (hold) 73.00 SAR
This report is for informational purposes only and is not investment advice. Sources: Hajras valuation & financials, Yahoo/SEC EDGAR, and investment-house targets.